Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Biomarin Pharmaceutical (BMRN) Q2 2017 Earnings
BMRN
4
May
Confirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
-0.53
0.01
0.54
1.08
Details
Expected EPS
-0.29
Actual EPS
-0.09
Surprise EPS
0.2
Surprise Percent
+68.97%
Description
Biomarin Pharmaceutical (BMRN) has reported earnings of -0.09 per share for Q2 2017.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login